A kaleidoscope of multiple ethnicities and evolutionary timelines make the Indian population inherently unique. Our genomic imprint also differs from the rest of the world. Particularly in the way our bodies respond to medicines, which have predominantly been researched on western populations. We are, for example, more susceptible to diabetes and heart disease.
Pioneering technologies in personal genomics now allow us to tailor our drug regimens, and even help predict our risk of developing heart disease.
Genessense is born of this vision: to provide the Indian population with insights into their unique genetic history, and to pave a road map for their future. Genessense’s genetic tests are based on data curated from exhaustive genomic analyses of the Indian population. Designed by scientists from MedGenome – India’s leading medical genomics company. MedGenome runs the largest DNA sequencing lab in South East Asia, with an immense, ever-growing repository of Indian genomic information. The data generated from this research is at the heart of Genessense’s test offerings.